Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with ALLO: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
ALLO
Allogene Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
ALLO
Allogene Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
478.34
▲
+3.70%
· post 480.00
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
ALLO
Allogene Therapeutics, Inc.
Change
1.19
▲
+6.25%
· post 1.19
Closed
Nov 4 '26
Mkt cap
$386.9M
Revenue
$5M
Q2 FY26
Revenue
—
vs
Compare
Closed
Nov 4 '26
AMGN
Amgen Inc
vs
ALLO
Allogene Therapeutics, Inc.
478.34
▲
+3.70%
post 480.00
Price
1.19
▲
+6.25%
post 1.19
$258.8B
Mkt cap
$386.9M
Q3 FY26
$10.4B
Revenue
$5M
Q2 FY26
FY25
$36.8B
Revenue
—
Change
Change
AMGN
478.34
▲
+3.70%
vs
ALLO
1.19
▲
+6.25%
Closed
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ALLO: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
ALLO, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only ALLO
12
PFE
Pfizer
supplier
NTRA
Natera
supplier
CLLS
Cellectis
supplier
—
Arbor Biotechnologies
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
supplier
8 more · ALLO chain
›